MDM shares its findings in journals and at professional conferences.



Publications

MDM has published in a variety of scientific journals. MDM’s publications are primarily model-focused and address a wide range of medical conditions. Furthermore, MDM personnel are frequent reviewers of manuscripts for the journals Medical Decision Making and Value in Health.

  • Furiak NM, Kahle-Wrobleski K, Callahan C, Klein TM, Klein RW, Siemers ER. Assessing benefits of screening asymptomatic populations for Alzheimer’s disease using computer modeling (submitted Alzheimer’s and Dementia 2010).

  • Klein R, Wielage R, Muehlenbein C, Liepa AM, Babineaux S, Lawson A, Schwartzberg L. Cost-Effectiveness of Pemetrexed as First-line Maintenance Therapy for Advanced Nonsquamous Non-Small Cell Lung Cancer (accepted J Thorac Oncol. 2010)

  • Furiak NM, Klein RW, Kahle-Wrobleski K, Siemers ER, Sarpong E, Klein TM. Modeling Screening, Prevention, and Delaying of Alzheimer's Disease: An Early-Stage Decision Analytic Model (accepted BMC Medical Informatics and Decision Making 2010).

  • Klein R, Muehlenbein C, Liepa AM, Babineaux S, Wielage R, Schwartzberg L. Cost-Effectiveness of Pemetrexed plus Cisplatin as First-line Therapy for Advanced Nonsquamous Non-Small Cell Lung Cancer J Thorac Oncol. 2009 Nov; 4(11): 1404-14

  • Krilov LR, Palazzi DL, Fernandes AW, Klein RW, Mahadevia PJ. Prevalence of Respiratory Syncytial Virus (RSV) Risk Factors and Cost Implications of Immunoprophylaxis to Infants 32-35 Weeks Gestation for Health Plans in the United States. Value in Health 2009 Aug 24; 13(1): 77-86.

  • Furiak NM, Ascher-Svanum H, Klein RW, Smolen LJ, Lawson AH, Conley RR, Culler SD. Cost-effectiveness model comparing olanzapine and other oral atypical antipsychotics in the treatment of schizophrenia in the United States. Cost Eff Resour Alloc. 2009 Apr 7; 7: 4.

  • Haas DM, Imperiale TF, Kirkpatrick PR, Klein RW, Zollinger TW, Golichowski AM. Tocolytic Therapy: A Meta-analysis and Decision Analysis. Obstretrics & Gynecology 2009; 113(3): 585-94.

  • Tafazzoli A, Roberts S, Ness R, Klein R, Dittus R. Probabilistic Cost-effectiveness Comparison of Screening Strategies for Colorectal Cancer. ACM Transactions on Modeling and Computer Simulation 2009; 19(2): 1-29.

  • Ascher-Svanum H, Zhu B, Faries DE, Furiak NM, Montgomery W. Medication adherence levels and differential use of mental-health services in the treatment of schizophrenia. BMC Res Notes. 2009 Jan 12; 2: 6.

  • Roberts S, Wang L, Klein R, Ness R, Dittus R. Development of a Simulation Model of Colorectal Cancer. ACM Transactions on Modeling and Computer Simulation 2008; 18(1): 1-30.

  • Smolen HJ, Cohen DJ, Samsa GP, Toole JF, Klein RW, Furiak NM, Lorell BH. Development, validation, and application of a microsimulation model to predict stroke and mortality in medically-managed asymptomatic patients with significant carotid artery stenosis. Value in Health 2007; 10(6): 489-97.

  • Imperiale TF, Klein RW, Chalasani N. A Cost-effectiveness Analysis of Variceal Ligation vs. Beta-blockers for Primary Prevention of Variceal Bleeding. Hepatology 2007; 45(4): 870-8.

  • Meadows ES, Klein R, Rousculp MD, Smolen L, Ohsfeldt RL Johnston JA. Cost-effectiveness of Preventative Therapies for Postmenopausal Women with Osteopenia. BMC Women's Health 2007; 7: 6. http://www.biomedcentral.com/content/pdf/1472-6874-7-6.pdf

  • Ness RM, Klein RW, Dittus, RS. Appendix G The Vanderbilt Colorectal Cancer Model. In Economic Models of Colorectal Cancer Screening in Average-Risk Adults: Workshop Summary. Pignone M, Russell L, Wagner J, eds. Washington DC, National Academies Press 2005. Available at:
    http://www.iom.edu/CMS/3798/15652/25197.aspx.

  • Ohsfeldt RL, Kreder KJ, Klein RW, Chrischilles EA. Cost-Effectiveness of Tamsulosin, Doxazosin, and Terazosin in the Treatment of Benign Prostatic Hyperplasia. Journal of Managed Care Pharmacy 2004; 10(5): 412-22.

  • Imperiale TF, Chalasani N, Klein RW. Measuring the Hemodynamic Response to Primary Pharmacoprophylaxis of Variceal Bleeding: A Cost-effectiveness Analysis. American Journal of Gastroenterology 2003; 98(12): 2742-50.

  • Ness RM, Holmes A, Klein R, Dittus R. Cost-utility of One-time Colonoscopic Screening for Colorectal Cancer at Various Ages. American Journal of Gastroenterology 2000; 95(7): 1800-11.

  • Ness RM, Holmes A, Klein R, Dittus R. Utility Valuations for Outcome States of Colorectal Cancer, American Journal of Gastroenterology 1999, 94(7): 1650-7.